These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 1719270)
21. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895 [TBL] [Abstract][Full Text] [Related]
22. Effects of enoximone on exercise tolerance in patients with mild to moderate heart failure. Itoh H; Taniguchi K; Doi M; Koike A; Sakuma A Am J Cardiol; 1991 Aug; 68(4):360-4. PubMed ID: 1830450 [TBL] [Abstract][Full Text] [Related]
23. [Acute hemodynamic effects of piroximone i.v. in patients with severe heart failure]. Scholz M; Kneissl GD; Winkelmann BW; Grohe G; Klittich P; Bussmann WD Z Kardiol; 1995 Oct; 84(10):827-33. PubMed ID: 7502570 [TBL] [Abstract][Full Text] [Related]
24. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure. Zipperle G; Butzer F; Dieterich HA; Heinrich F Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873 [TBL] [Abstract][Full Text] [Related]
25. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy. Leier CV; Binkley PF; Starling RC; Huss-Randolph P Am Heart J; 1989 May; 117(5):1092-8. PubMed ID: 2523634 [TBL] [Abstract][Full Text] [Related]
26. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output]. Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831 [TBL] [Abstract][Full Text] [Related]
27. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group. Narahara KA Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806 [TBL] [Abstract][Full Text] [Related]
28. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415 [TBL] [Abstract][Full Text] [Related]
29. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure]. Saborowski F; Peters P; Schneider M Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900 [TBL] [Abstract][Full Text] [Related]
30. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure. Leier CV; Meiler SE; Matthews S; Unverferth DV Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864 [TBL] [Abstract][Full Text] [Related]
31. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile. Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004 [TBL] [Abstract][Full Text] [Related]
32. Acute clinical benefits of a new inotropic agent AR-L 115 BS after i.v. and oral administration. el Allaf D; D'Orio V; Cremers S; Carlier J G Ital Cardiol; 1984 Oct; 14(10):830-4. PubMed ID: 6519393 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure. Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868 [TBL] [Abstract][Full Text] [Related]
34. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Uretsky BF; Jessup M; Konstam MA; Dec GW; Leier CV; Benotti J; Murali S; Herrmann HC; Sandberg JA Circulation; 1990 Sep; 82(3):774-80. PubMed ID: 2144216 [TBL] [Abstract][Full Text] [Related]
35. [Acute effect of enoximone and captopril in patients with heart failure]. Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901 [TBL] [Abstract][Full Text] [Related]
36. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Petein M; Levine TB; Cohn JN Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778 [TBL] [Abstract][Full Text] [Related]
37. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure. Chatterjee K; Kereiakes D; Viquerat C; Podolin R Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866 [TBL] [Abstract][Full Text] [Related]